Evidence map›Paper›PMID 19728026›Full record

ReviewInternational journal of hematology2009

Plasma cell leukemia producing monoclonal immunoglobulin E.

Yuzuru Takemura, Masanobu Ikeda, Kahori Kobayashi, Yuji Nakazawa, Yuichi Mori, Toshimi Mitsuishi, Hiroki Ishigame, Fumiko Kameko, Kiyotaka Fujita, Ryo Ichinohasama

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in International journal of hematology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yuzuru TakemuraDepartment of Clinical Laboratories, Saku Central Hospital, 197 Usuda, Saku, Nagano, 384-0301, Japan. yuzurutakemura@nifty.com.
Masanobu IkedaDepartment of Clinical Laboratories, Saku Central Hospital, 197 Usuda, Saku, Nagano, 384-0301, Japan.
Kahori KobayashiDepartment of Clinical Laboratories, Saku Central Hospital, 197 Usuda, Saku, Nagano, 384-0301, Japan.
Yuji NakazawaDepartment of Clinical Laboratories, Saku Central Hospital, 197 Usuda, Saku, Nagano, 384-0301, Japan.
Yuichi MoriDepartment of Internal Medicine, Saku Central Hospital, Saku, Japan.
Toshimi MitsuishiDepartment of Internal Medicine, Saku Central Hospital, Saku, Japan.
Hiroki IshigameDepartment of Clinical Pathology, Saku Central Hospital, Saku, Japan.
Fumiko KamekoDepartment of Biomedical Laboratory Sciences, School of Health Sciences, Shinshu University, Matsumoto, Japan.
Kiyotaka FujitaDepartment of Medical Crisis Management, Chiba Institute of Science, Choshi, Japan.
Ryo IchinohasamaDivision of Hematopathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Saku Central Hospital · JPChiba Institute of Science · JPShinshu University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 78-year-old male with lumbar pain and dim consciousness presented the clinical pictures of plasma cell leukemia (PCL) producing a large amount of monoclonal immunoglobulin E (IgE)/kappa protein. Laboratory investigation demonstrated an elevated serum calcium level and renal dysfunction. Systemic bone X-ray survey disclosed only a solitary osteolytic lesion. Circulating plasma cells demonstrated CD19(-)/CD56(-) and MPC-1(-)/CD49e(-)/CD45(+/-), the latter indicating the immature phenotype of the tumor cells. Bone marrow was occupied with immature, atypical plasma cells, of which cytoplasms were positive for IgE by direct immunofluorescence analysis. Chromosomes revealed a translocation of (11;14)(q13;q32), which is concordant with cyclinD1-protein overexpression by immunohistochemistry. He was treated with dexamethasone and vincristine, which somewhat improved the laboratory findings. He died of tumor progression after 4-month admission. The clinical and biological characteristics of IgE-producing PCL, a very rare type of plasma cell dyscrasia, are discussed, reviewing the past literature.

Indexed as

AgedAntibodies, MonoclonalBone NeoplasmsFluorescent Antibody Technique, DirectHumansImmunoglobulin EImmunoglobulin kappa-ChainsLeukemia, Plasma CellMaleAntibodies, MonoclonalImmunoglobulin EImmunoglobulin kappa-Chains

Identifiers

PMID19728026
OpenAlexW1988950257

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.